Evidence map›Paper›PMID 32161092›Full record

ReviewJournal of clinical microbiology2020

Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options.

Suliman Khan, Rabeea Siddique, Muhammad Adnan Shereen, Ashaq Ali, Jianbo Liu, Qian Bai, Nadia Bashir, Mengzhou Xue

Erratum issuedAbstract readReview
In one paragraph

Review in Journal of clinical microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 152 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. COVID-19 Pandemic: Therapeutic Strategies and Vaccines.International journal of molecular sciences · 2023
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Suliman KhanDepartment of Cerebrovascular Diseases, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China Suliman.khan18@mails.ucas.ac.cn xuemengzhou@zzu.edu.cn.ORCID 0000-0003-4954-0748
Rabeea SiddiqueDepartment of Cerebrovascular Diseases, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Muhammad Adnan ShereenState Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.
Ashaq AliWuhan institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Jianbo LiuDepartment of Respiratory Medicine, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Qian BaiDepartment of Cerebrovascular Diseases, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Nadia BashirState Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.
Mengzhou XueDepartment of Cerebrovascular Diseases, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China Suliman.khan18@mails.ucas.ac.cn xuemengzhou@zzu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The new decade of the 21

Indexed as

AnimalsBetacoronavirusChinaCoronavirus InfectionsCOVID-19Disease OutbreaksGenetic VariationGenome, ViralHumansPandemicsPneumonia, ViralSARS-CoV-2Zoonosesnovel coronavirusoutbreaktherapeuticstransmission

Identifiers

PMID32161092
PMCPMC7180238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.